{
  "main_header": {
    "sid": 622974,
    "name": "Panacea Biotec",
    "stock_name": "Panacea Biotec",
    "full_name": "Panacea Biotec Ltd",
    "name_url": "stocks-analysis/panacea-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "452.90",
    "chg": 16.95,
    "chgp": "3.89%",
    "dir": 1,
    "prev_price": "435.95",
    "mcapval": "2,774.05 Cr",
    "mcap": "Small Cap",
    "scripcode": 531349,
    "symbol": "PANACEABIO",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE922B01023",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:16 AM",
    "bse_nse_vol": "1.09 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/panacea-biotec-622974-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Panacea Biotec Experiences Surge in Trading Activity Amid Sector Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-466-55-1695844",
        "imagepath": "",
        "date": "2025-04-03 11:00:16",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown significant activity today as it hit its upper circuit limit. The stock reached an intraday high of Rs 466.55, reflecting a 5% increase from its previous trading session. The last traded price stood at Rs 457.90, marking an absolute change of Rs 13.55, or a 3.05% increase.\n\nToday's trading volume was notable, with approximately 4.75 lakh shares exchanged, resulting in a turnover of around Rs 22.09 crore. The stock has been performing well against its moving averages, trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. \n\nDespite underperforming its sector by 1.75%, the Pharmaceuticals & Drugs sector overall gained 2.56% today. Additionally, there was a rise in investor participation, with delivery volume increasing by 6.66% compared to the 5-day average. \n\nIn summary, Panacea Biotec's performan..."
      },
      {
        "title": "Panacea Biotec Faces Trading Volatility Amid Increased Investor Participation and Sector Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-stock-hits-lower-circuit-limit-at-rs-429-55-amid-market-decline-1694533",
        "imagepath": "",
        "date": "2025-04-03 10:00:05",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 443.35, reflecting a decline of Rs 8.80 or 1.95%. The stock's performance was marked by a low price of Rs 429.55, which contributed to its circuit limit status.\n\nThroughout the trading session, Panacea Biotec reached an intraday high of Rs 466.55, representing a 5% price band. The total traded volume was approximately 2.19 lakh shares, resulting in a turnover of Rs 9.76 crore. Despite the day's challenges, the stock outperformed its sector, which gained 3.59%, and showed resilience by trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.\n\nInvestor participation also saw a rise, with delivery volume increasing by 6.66% compared to the 5-day average. Overall, Panacea Biotec's performance today reflects t..."
      },
      {
        "title": "Panacea Biotec Faces Volatility Amid Significant Trading Activity in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-hits-lower-circuit-limit-with-intraday-low-of-rs-429-55-1674275",
        "imagepath": "",
        "date": "2025-04-02 11:00:04",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today as the stock hit its lower circuit limit. The last traded price was Rs 451.60, reflecting a decline of Rs 0.55 or 0.12%. The stock reached an intraday low of Rs 429.55, marking a 5% drop from its previous close.\n\nThe total traded volume stood at approximately 0.54143 lakh shares, resulting in a turnover of Rs 2.40 crore. Despite the day's challenges, Panacea Biotec has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a mixed performance trend over the short to medium term.\n\nIn terms of market position, the stock underperformed its sector by 0.42%, with a 1D return of -0.92%, while the sector and Sensex reported marginal gains of 0.01% and 0.45%, respectively. Notably, the weighted average price suggests that more volume was traded closer..."
      },
      {
        "title": "Panacea Biotec Experiences Surge in Trading Activity Amid Positive Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-463-3-2-1673689",
        "imagepath": "",
        "date": "2025-04-02 10:00:54",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has shown significant activity today as it hit its upper circuit limit. The stock reached a high price of Rs 463.3, reflecting a change of Rs 8.55 or 1.94% from its previous close. The last traded price stood at Rs 449.8, with the stock experiencing an intraday low of Rs 436.55.\n\nToday's trading volume was notable, with a total of 3.19 lakh shares exchanged, resulting in a turnover of approximately Rs 14.55 crore. Despite underperforming its sector by 1.4%, Panacea Biotec is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its recent performance.\n\nInvestor participation has also increased, with delivery volume rising by 92.09% compared to the 5-day average. The stock's liquidity remains robust, supporting trade sizes of Rs 0.17 crore based on 2% of the 5-day av..."
      },
      {
        "title": "Panacea Biotec Shows Strong Technical Trends Amid Market Volatility and Growth Potential",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotecs-technical-trend-upgrades-from-mildly-bullish-to-bullish-amid-strong-performance-2-1670555",
        "imagepath": "",
        "date": "2025-04-02 08:05:42",
        "description": "Panacea Biotec, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 448.00, showing a notable increase from the previous close of 441.20. Over the past year, Panacea Biotec has demonstrated impressive performance, with a stock return of 237.10%, significantly outpacing the Sensex return of 2.72% during the same period.\n\nThe technical summary indicates a bullish sentiment across various indicators. The MACD and Bollinger Bands both reflect bullish trends on weekly and monthly charts, while daily moving averages also align with this positive outlook. However, the KST shows a mildly bearish trend on a weekly basis, suggesting some mixed signals in the short term.\n\nIn terms of price movement, the stock has seen a 52-week high of 489.00 and a low of 112.70, highlighting its volatility. T..."
      },
      {
        "title": "Panacea Biotec Hits Upper Circuit Limit Amidst Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-463-3-1659273",
        "imagepath": "",
        "date": "2025-04-01 11:00:31",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown remarkable activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 463.3, reflecting a notable increase of 5% from its previous close, with an absolute change of Rs 22.05. This performance outpaced the sector, which recorded a 1D return of -1.09%.\n\nThe total traded volume for Panacea Biotec today was approximately 0.80923 lakh shares, resulting in a turnover of Rs 3.70 crore. The stock has been on a positive trajectory, gaining for the last two days and achieving a cumulative return of 5.33% during this period. Additionally, Panacea Biotec is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance relative to these benchmarks.\n\nDespite a slight decline in delivery volume, the stock remains liquid enough for trading, with ..."
      },
      {
        "title": "Panacea Biotec Shows Mixed Technical Trends Amid Strong Yearly Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotecs-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-decline-1575745",
        "imagepath": "",
        "date": "2025-03-25 08:03:10",
        "description": "Panacea Biotec, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 444.00, slightly down from the previous close of 445.00. Over the past year, Panacea Biotec has demonstrated significant performance, with a remarkable return of 234.09%, far surpassing the Sensex's return of 7.07% during the same period.\n\nThe technical summary indicates a mixed outlook, with various indicators showing differing trends. The MACD reflects a mildly bearish stance on a weekly basis while remaining bullish on a monthly scale. The Bollinger Bands suggest a mildly bullish trend weekly and bullish monthly, indicating some volatility but overall positive momentum. Daily moving averages are bullish, while the KST shows a mildly bearish trend weekly but bullish monthly.\n\nIn terms of stock performance, Panacea..."
      },
      {
        "title": "Panacea Biotec Faces Trading Challenges Amid Declining Investor Participation and Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-hits-lower-circuit-limit-closing-at-rs-425-4-after-4-99-decline-1574620",
        "imagepath": "",
        "date": "2025-03-24 12:00:04",
        "description": "Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today as the stock hit its lower circuit limit. The last traded price stood at Rs 425.4, reflecting a decline of Rs 22.35 or 4.99% from the previous close. The stock's performance today has underperformed its sector by 5.62%, marking a consecutive fall over the last two days with a total decline of 5.62% during this period.\n\nIntraday, Panacea Biotec reached a high of Rs 458.3 before dropping to a low of Rs 425.4. The total traded volume was approximately 1.07 lakh shares, resulting in a turnover of around Rs 4.67 crore. Notably, the stock opened with a gain of 2.29% earlier in the day but could not sustain this momentum.\n\nDespite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, investor participation has waned, with delivery volume decreasing by 72.11% compar..."
      },
      {
        "title": "Panacea Biotec Faces Intense Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/panacea-biotec-faces-selling-pressure-declines-4-43-amid-ongoing-losses-over-two-days-1574384",
        "imagepath": "",
        "date": "2025-03-24 11:15:07",
        "description": "Panacea Biotec Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, resulting in a total decline of 5.88%. Today, it opened with a gain of 2.11% but quickly fell to an intraday low of Rs 425.3, marking a decrease of 4.43%. In contrast, the Sensex has shown a positive performance of 1.12% today.\n\nDespite a strong performance over the past year, where Panacea Biotec has surged by 220.02%, the recent trend indicates a shift in market sentiment. Over the last week, the stock gained 10.11%, outperforming the Sensex's 4.85%, but the current selling pressure raises questions about sustainability. \n\nThe stock's performance relative to the Sensex highlights its volatility, with a year-to-date increase of 2.56% compared to the Sensex's decline of 0.47%. Additionally, Panacea Biotec has consistently traded ..."
      }
    ],
    "total": 75,
    "sid": "622974",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/panacea-biotec-622974"
  },
  "announcements": [
    {
      "caption": "Details Of Shares Dematerialized During March 2025",
      "datetime": "07-Apr-2025",
      "details": "This is to inform that no share has been dematerialised during the month March 2025. A copy of certificate obtained from the Companys RTA regarding number of shares dematerialised as on 31.03.2025 is enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "03-Apr-2025",
      "details": "We are enclosing herewith a certificate dated April 02 2025 issued by Skyline Financial Services Private Limited Registrar and Transfer Agent of the Company confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "01-Apr-2025",
      "details": "We would like to inform you that Mr. Narotam Kumar Juneja non-executive non independent director of the Company was re-appointed as director liable to retire by rotation in the AGM held on 27.09.2024 for a period upto 31.03.2025. Accordingly he has completed his tenure as non-executive non-independent director and consequently ceased to be director of the Company on 31.03.2025. Similarly he has also completed his tenure as Whole-time Director in the Companys material subsidiary Panacea Biotec Pharma Ltd. on 31.03.2025. The details as required under SEBI Circular dated 13.07.2023 are attached herewith.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Panacea Biotec Ltd has declared <strong>75%</strong> dividend, ex-date: 19 Sep 11",
          "dt": "2011-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Panacea Biotec Experiences Surge in Trading Activity Amid Sector Gains

2025-04-03 11:00:16

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown significant activity today as it hit its upper circuit limit. The stock reached an intraday high of Rs 466.55, reflecting a 5% increase from its previous trading session. The last traded price stood at Rs 457.90, marking an absolute change of Rs 13.55, or a 3.05% increase. Today's trading volume was notable, with approximately 4.75 lakh shares exchanged, resulting in a turnover of around Rs 22.09 crore. The stock has been performing well against its moving averages, trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Despite underperforming its sector by 1.75%, the Pharmaceuticals & Drugs sector overall gained 2.56% today. Additionally, there was a rise in investor participation, with delivery volume increasing by 6.66% compared to the 5-day average. In summary, Panacea Biotec's performan...

Read More

Panacea Biotec Faces Trading Volatility Amid Increased Investor Participation and Sector Resilience

2025-04-03 10:00:05

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today, hitting its lower circuit limit. The stock closed at Rs 443.35, reflecting a decline of Rs 8.80 or 1.95%. The stock's performance was marked by a low price of Rs 429.55, which contributed to its circuit limit status. Throughout the trading session, Panacea Biotec reached an intraday high of Rs 466.55, representing a 5% price band. The total traded volume was approximately 2.19 lakh shares, resulting in a turnover of Rs 9.76 crore. Despite the day's challenges, the stock outperformed its sector, which gained 3.59%, and showed resilience by trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Investor participation also saw a rise, with delivery volume increasing by 6.66% compared to the 5-day average. Overall, Panacea Biotec's performance today reflects t...

Read More

Panacea Biotec Faces Volatility Amid Significant Trading Activity in Pharmaceuticals Sector

2025-04-02 11:00:04

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today as the stock hit its lower circuit limit. The last traded price was Rs 451.60, reflecting a decline of Rs 0.55 or 0.12%. The stock reached an intraday low of Rs 429.55, marking a 5% drop from its previous close. The total traded volume stood at approximately 0.54143 lakh shares, resulting in a turnover of Rs 2.40 crore. Despite the day's challenges, Panacea Biotec has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a mixed performance trend over the short to medium term. In terms of market position, the stock underperformed its sector by 0.42%, with a 1D return of -0.92%, while the sector and Sensex reported marginal gains of 0.01% and 0.45%, respectively. Notably, the weighted average price suggests that more volume was traded closer...

Read More

Panacea Biotec Experiences Surge in Trading Activity Amid Positive Market Sentiment

2025-04-02 10:00:54

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs sector, has shown significant activity today as it hit its upper circuit limit. The stock reached a high price of Rs 463.3, reflecting a change of Rs 8.55 or 1.94% from its previous close. The last traded price stood at Rs 449.8, with the stock experiencing an intraday low of Rs 436.55. Today's trading volume was notable, with a total of 3.19 lakh shares exchanged, resulting in a turnover of approximately Rs 14.55 crore. Despite underperforming its sector by 1.4%, Panacea Biotec is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its recent performance. Investor participation has also increased, with delivery volume rising by 92.09% compared to the 5-day average. The stock's liquidity remains robust, supporting trade sizes of Rs 0.17 crore based on 2% of the 5-day av...

Read More

Panacea Biotec Shows Strong Technical Trends Amid Market Volatility and Growth Potential

2025-04-02 08:05:42

Panacea Biotec, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 448.00, showing a notable increase from the previous close of 441.20. Over the past year, Panacea Biotec has demonstrated impressive performance, with a stock return of 237.10%, significantly outpacing the Sensex return of 2.72% during the same period. The technical summary indicates a bullish sentiment across various indicators. The MACD and Bollinger Bands both reflect bullish trends on weekly and monthly charts, while daily moving averages also align with this positive outlook. However, the KST shows a mildly bearish trend on a weekly basis, suggesting some mixed signals in the short term. In terms of price movement, the stock has seen a 52-week high of 489.00 and a low of 112.70, highlighting its volatility. T...

Read More

Panacea Biotec Hits Upper Circuit Limit Amidst Broader Market Decline

2025-04-01 11:00:31

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has shown remarkable activity today, hitting its upper circuit limit. The stock reached an intraday high of Rs 463.3, reflecting a notable increase of 5% from its previous close, with an absolute change of Rs 22.05. This performance outpaced the sector, which recorded a 1D return of -1.09%. The total traded volume for Panacea Biotec today was approximately 0.80923 lakh shares, resulting in a turnover of Rs 3.70 crore. The stock has been on a positive trajectory, gaining for the last two days and achieving a cumulative return of 5.33% during this period. Additionally, Panacea Biotec is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong performance relative to these benchmarks. Despite a slight decline in delivery volume, the stock remains liquid enough for trading, with ...

Read More

Panacea Biotec Shows Mixed Technical Trends Amid Strong Yearly Performance

2025-03-25 08:03:10

Panacea Biotec, a small-cap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 444.00, slightly down from the previous close of 445.00. Over the past year, Panacea Biotec has demonstrated significant performance, with a remarkable return of 234.09%, far surpassing the Sensex's return of 7.07% during the same period. The technical summary indicates a mixed outlook, with various indicators showing differing trends. The MACD reflects a mildly bearish stance on a weekly basis while remaining bullish on a monthly scale. The Bollinger Bands suggest a mildly bullish trend weekly and bullish monthly, indicating some volatility but overall positive momentum. Daily moving averages are bullish, while the KST shows a mildly bearish trend weekly but bullish monthly. In terms of stock performance, Panacea...

Read More

Panacea Biotec Faces Trading Challenges Amid Declining Investor Participation and Volatility

2025-03-24 12:00:04

Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, experienced significant trading activity today as the stock hit its lower circuit limit. The last traded price stood at Rs 425.4, reflecting a decline of Rs 22.35 or 4.99% from the previous close. The stock's performance today has underperformed its sector by 5.62%, marking a consecutive fall over the last two days with a total decline of 5.62% during this period. Intraday, Panacea Biotec reached a high of Rs 458.3 before dropping to a low of Rs 425.4. The total traded volume was approximately 1.07 lakh shares, resulting in a turnover of around Rs 4.67 crore. Notably, the stock opened with a gain of 2.29% earlier in the day but could not sustain this momentum. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, investor participation has waned, with delivery volume decreasing by 72.11% compar...

Read More

Panacea Biotec Faces Intense Selling Pressure Amid Recent Price Declines

2025-03-24 11:15:07

Panacea Biotec Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced consecutive losses over the past two days, resulting in a total decline of 5.88%. Today, it opened with a gain of 2.11% but quickly fell to an intraday low of Rs 425.3, marking a decrease of 4.43%. In contrast, the Sensex has shown a positive performance of 1.12% today. Despite a strong performance over the past year, where Panacea Biotec has surged by 220.02%, the recent trend indicates a shift in market sentiment. Over the last week, the stock gained 10.11%, outperforming the Sensex's 4.85%, but the current selling pressure raises questions about sustainability. The stock's performance relative to the Sensex highlights its volatility, with a year-to-date increase of 2.56% compared to the Sensex's decline of 0.47%. Additionally, Panacea Biotec has consistently traded ...

Read More

View All News